Asbestos Research Today is a free monthly online journal that collates and summarizes the latest research about Asbestos, including details on mesothelioma, lung disease, dangers, effects, risks.

Volume 2 (2005), Issue 3 (March)

1. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations.
   Eur J Cardiothorac Surg, 27(3): 373-8. [Abstract] [Full-text]
2. The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression.
   Mol Cell Biol, 25(6): 2384-94. [Abstract] [Full-text]
3. Yeast cells long-term interaction with asbestos fibers.
   Colloids Surf B Biointerfaces, 41(4): 277-83. [Abstract] [Full-text]
4. Farnesyltransferase inhibitors and human malignant pleural mesothelioma: a first-step comparative translational study.
   Clin Cancer Res, 11(5): 2026-37. [Abstract] [Full-text]
5. Assessment of immunological competence and SV40 specific recall immunity in malignant pleural mesothelioma.
   Vaccine, 23(17): 2399-402. [Abstract] [Full-text]
6. Mesothelioma mortality in Great Britain from 1968 to 2001.
   Occup Med (Lond), 55(2): 79-87. [Abstract] [Full-text]
7. The biopersistence of Canadian chrysotile asbestos following inhalation: final results through 1 year after cessation of exposure.
   Inhal Toxicol, 17(1): 1-14. [Abstract] [Full-text]
8. Pemetrexed therapy for malignant pleural mesothelioma.
   Ann Pharmacother, 39(4): 678-83. [Abstract] [Full-text]
9. Changing trends in US mesothelioma incidence.
   Occup Environ Med, 62(4): 270. [Abstract] [Full-text]
10. Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE).
    Lung Cancer, 48(1): 19-29. [Abstract] [Full-text]
11. Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma.
    Eur J Surg Oncol, 31(3): 314-20. [Abstract] [Full-text]
12. Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.
    Clin Cancer Res, 11(6): 2300-4. [Abstract] [Full-text]
13. Tumor necrosis factor enhances SN38-mediated apoptosis in mesothelioma cells.
    Cancer, 103(7): 1503-18. [Abstract] [Full-text]
14. Induction of CD69 antigen expression in peripheral blood mononuclear cells on exposure to silica, but not by asbestos/chrysotile-A.
    Immunol Lett, 98(1): 145-52. [Abstract] [Full-text]
15. Hyaluronan synthase expression in pleural malignant mesotheliomas.
    Virchows Arch, 446(3): 246-50. [Abstract] [Full-text]
16. Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models.
    Int J Cancer, 115(1): 142-7. [Abstract] [Full-text]

© 2004-2008 Asbestos Research Today. All Rights Reserved.